PATENT CLAIM ANALYSIS

Application Number: 15731991
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "094200"]

Abstract:
The Cloning and Expression of Comosain's Minigene and the Methods and Compositions for treating and/or preventing various types of cancer which comprise administered an effective amount of Glyco-polypeptides and Bioflavonoids such as Comosain, Ananase, Bromelainases, Trypsin, Pepsin, Quercetin, Rutin, Naringenin, Genistein, Hesperetin, etc and/or a mixture thereof.

Claim (Index 3):
3 ). The method of  claim 1 : Wherein the Glycopolypeptides, such as Comosain, Bromelainases, Ananase, are derived from Anana Comosus & Pepsin and Trypsin are from Animal Gastrointestinal juice. Quercetin, Rutin, Genistein, Naringenin, Hesperetin, are derived from Fructus Crataegus and Citrus Fruits, and the mixture of above complex is administered in the form of pharmaceutical composition containing an effective amount of the above components and pharmaceutically acceptable excipients, carriers or diluents.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.37209
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15272826', '14003629', '12861152', '11214831', '10617943']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.716688360165279
- 35 USC 102 Novelty (BERT): 0.4950562862952843
- Combined Prediction Score: 0.6945251527782796
- Mean Citation Score: 172.64342000000005
- Max Citation Score: 186.47795
- Similarity Product: 119.81166850959065

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test